Due to limited data on the long-term effectiveness of these medications, this study assessed real-world weight loss with semaglutide 2.4 mg or tirzepatide after 1 year in patients with overweight or obesity and without T2DM
Tirzepatide, a novel GLP-1/GIP dual receptor agonist, offers a synergistic effect and demonstrates unique advantages in glucose management and weight control
Cheeks: While bruising can occur with cheek fillers, it is generally less common than in more vascular areas like the tear troughs and lips
The water used in the formulation is purified to USP Purified Water specifications, then further processed through reverse osmosis, deionization, and final filtration prior to the addition of the preservative
Preclinical models demonstrate accelerated wound repair and anti-inflammatory activity [3] , though human clinical data remain limited to early-phase safety trials and small case reports [4] [5]
Your Goal Start by selecting your wellness goal or main area of focus